Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quehenberger

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 19, 2023
Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane OxygenationAndrea Kornfehl, Roman Brock, Thomas Staudinger, et al.
Thrombosis Research|September 3, 2014
Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometryDieter Adelmann, Marion Wiegele, Rudolf Karl Wohlgemuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Rainer Vormittag, Daniela Dunkler, et al.
Clinical Chemistry|May 19, 2007
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variantCihan Ay, Lea V Jungbauer, Thomas Sailer, et al.
International Journal of Laboratory Hematology|July 24, 2018
Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin timeSteve Kitchen, Ulrich Geisen, Janos Kappelmayer, et al.
Journal of Vascular Surgery|March 29, 2003
Superficial thrombophlebitis and risk for recurrent venous thromboembolismVerena Schönauer, Paul A Kyrle, Ansgar Weltermann, et al.
Transfusion|February 22, 2011
Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteersPetra Jilma-Stohlawetz, Friedrich W Kursten, Claudia Walasek, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 23, 2015
A model comparing how rapidly transfusion of solvent detergent plasma restores clotting factors versus infusion of albumin-salinePetra Jilma-Stohlawetz, Friedrich W Kursten, Michaela Horvath, et al.
The Annals of Thoracic Surgery|December 23, 2008
Platelet dysfunction in outpatients with left ventricular assist devicesBarbara Steinlechner, Martin Dworschak, Beatrice Birkenberg, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 19, 2023
Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane OxygenationAndrea Kornfehl, Roman Brock, Thomas Staudinger, et al.
Thrombosis Research|September 3, 2014
Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometryDieter Adelmann, Marion Wiegele, Rudolf Karl Wohlgemuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Rainer Vormittag, Daniela Dunkler, et al.
Clinical Chemistry|May 19, 2007
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variantCihan Ay, Lea V Jungbauer, Thomas Sailer, et al.
International Journal of Laboratory Hematology|July 24, 2018
Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin timeSteve Kitchen, Ulrich Geisen, Janos Kappelmayer, et al.
Journal of Vascular Surgery|March 29, 2003
Superficial thrombophlebitis and risk for recurrent venous thromboembolismVerena Schönauer, Paul A Kyrle, Ansgar Weltermann, et al.
Transfusion|February 22, 2011
Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteersPetra Jilma-Stohlawetz, Friedrich W Kursten, Claudia Walasek, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 23, 2015
A model comparing how rapidly transfusion of solvent detergent plasma restores clotting factors versus infusion of albumin-salinePetra Jilma-Stohlawetz, Friedrich W Kursten, Michaela Horvath, et al.
The Annals of Thoracic Surgery|December 23, 2008
Platelet dysfunction in outpatients with left ventricular assist devicesBarbara Steinlechner, Martin Dworschak, Beatrice Birkenberg, et al.
Pageof 14